[Today's Headlines]新突破！异体脂肪干细胞治疗儿童1型糖尿病获临床证实：安全有效，显著减糖降药
干细胞治疗儿童1型糖尿病代表着超越单纯胰岛素替代的疾病修饰疗法的重要研发方向。1型糖尿病（T1DM）是一种由自身免疫介导的疾…… [Details]
-
新突破！异体脂肪干细胞治疗儿童1型糖尿病获临床证实：安全有效，显著减糖降药
干细胞治疗儿童1型糖尿病代表着超越单纯胰岛素替代的疾病修饰疗法的重要研发方向。1……
-
干细胞治疗慢性肾病2期的临床试验获积极结果：低剂量单次给药稳定肾功能且安全性良好
慢性肾脏病（CKD）影响着全球约10%的人口，其中约30%会进展至3B‑5期。其病理特征主……
-
一剂新药，一个起点：中国首款干细胞新药获批周年回顾，能否撬动万亿产业？
2026年1月2号恰逢中国细胞治疗领域迎来历史性里程碑的一周年。2025年1月2日，中国……
-
干细胞为什么能够治疗中风？凭借的机制原理是什么？——结合最新临床试验数据的结果来了
在全球范围内，中风（脑卒中）是导致死亡和残疾的主要原因之一，患者常面临漫长的康……
New Releases
The truth about why stem cell therapy hasn't made it into hospitals yet, even in 2025, isn't really that simple!
最近，关于干细胞的讨论又一次登上热搜。 不少人留言问：“为什么干细胞治疗还没有进入医院呢”？ “三甲医院是不是不能再用干细胞了？”“是不是干细胞项目都被叫停了？”“之前预约的治疗是不是要退了？” 事实上——“国家……
The Health Commission will include stem cell therapy in the key specialties! 8 types of intractable diseases to welcome a new dawn!
2025年，国家卫健委在《国家重点研发计划2025年度项目申报指南》中，首次将“干细胞研究与器官修复”列为五大重点方向之一。这意味着干细胞从实验室走向临床的步伐正在全面提速。央视也特别报道：我国正加快推动干……
Stem Cell Therapy for Autism: Phase I Clinical Trial Evaluates Efficacy by Brain Biomarkers | Mechanistic Study
In recent years, researchers have proposed a variety of brain imaging techniques as potential biomarkers for assessing autism spectrum disorders (ASD), including electroencephalography (EEG), functional magnetic resonance imaging (fMRI), structural magnetic resonance imaging (MRI), and diffusion tensor imaging (DTI). Among them, EEG is recognized for its high temporal resolution (......
Stem Cell Therapy for Severe Limb Ischemia: Phase I Clinical Trial Reports Safety and Feasibility | Patient Hope
Recently, the international journal Stem Cell Research & Therapy published a Phase 1 clinical study led by Zeinab Shirbaghaee's team, which explored the feasibility and preliminary efficacy of using placental-derived mesenchymal stem cells (MSCs) to treat patients with severe limb ischemia (CLI) (trial ......
Science 丨 What is stem cell therapy? How can it help you?
Stem cell therapy is a regenerative medicine method that utilizes stem cells, special cells in the body with the potential for self-renewal and multidirectional differentiation, to repair, replace or regenerate damaged tissues and organs. They bring new possibilities for the treatment of many chronic diseases, intractable injuries and illnesses. This guide will take you through a comprehensive understanding of stem cells ......
Reshaping the future of neurodegenerative disease treatment: advances in clinical translation of stem cells and engineered exosomes
Neurodegenerative diseases, such as Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS), have been a major challenge for modern medicine. With the accelerated aging of the population, the prevalence of these diseases is rising year by year, which not only seriously affects the quality of life of patients, but also poses a significant challenge to the social healthcare system ......
Stem Cell Therapy for Parkinson's Disease Advances: 3 Infusions Safe and Improved Motor Function Confirmed in Phase II Clinic
Since the 1960s, when Carlsson, Hornykiewicz, Cotzias, and Yahr discovered nigrostriatal dopamine deficiency in patients with Parkinson's disease (PD) and introduced dopamine replacement therapy, a plethora of pharmacologic and neuromodulatory treatments have been effective in alleviating motor symptoms. In the field of regenerative medicine, PD has been a cell therapy ......
Is Stem Cell Therapy for Parkinson's Disease a Scam?2025 Update and Guide to Avoiding Pitfalls
近几年，关于”干细胞可以治好帕金森病”的消息在网络上频频出现，甚至有一些机构打着”完完全全彻底根治帕金森病”的旗号收取高额费用，让不少患者心动又疑惑：究竟是医学突破还是精心设计的骗局？ 其实要搞清楚这个……
Which Parkinson's patients are suitable for stem cell therapy? Experts announce 4 major evaluation criteria
近几年，干细胞治疗帕金森病在医学界热度不断上升。理论上，这类疗法可以修复受损的多巴胺能神经元、改善运动功能障碍，甚至有望减缓”开关现象”等核心症状的进展；但它并非万能钥匙，并非所有帕金森病患者都适合尝……
Stem cell therapy for Parkinson's disease costs revealed: a comparison of domestic and international price differences in 2025
在帕金森病治疗领域，干细胞治疗正逐渐崭露头角，成为众多帕金森病患者关注的焦点。这种创新疗法为传统治疗手段难以有效控制病情的患者，带来了新的希望曙光。 但大家盯着疗效的同时，心里总绕不开一个实在问题：……
Three Parkinson's disease patients in their own words: the complete experience and results of participating in a Parkinson's disease stem cell clinical trial!
在帕金森病治疗中，干细胞疗法正从实验室走向临床应用。相比传统疗法，它通过神经再生和免疫调节，为神经修复带来新希望。真实患者的经历比媒体报道更能反映实际效果。以下是3位参与干细胞治疗的帕金森病患者的亲……
Is Stem Cell Therapy for Stroke a Scam?2025 Updated Efficacy Analysis and Pitfall Avoidance Guide
近几年，关于”干细胞可以治愈脑中风”的消息在网络上频频出现，甚至有一些机构打着”彻底逆转脑损伤、恢复如初”的旗号收取高额费用，让不少患者和家属心动又疑惑：究竟是医学突破还是精心……
Meta-analysis Confirms Short-Term Efficacy of Stem Cell Therapy for Erectile Dysfunction (based on 75 patients from 6 studies)
勃起功能障碍（ED）是一个涉及神经、血管与内分泌通路整合的复杂生理过程，其机制包括动脉扩张、海绵体平滑肌松弛以及静脉闭合机制的激活。ED被定义为无法获得或维持足够勃起以完成满意性生活的状况，它不仅影响患……
Stem cell therapy for stroke costs revealed: domestic and international price comparisons in 2025
在中风治疗领域，干细胞治疗正逐渐崭露头角，成为众多中风患者关注的焦点。这种创新疗法为传统治疗手段难以有效控制病情的患者，带来了新的希望曙光。 但大家盯着疗效的同时，心里总绕不开一个实在问题：干细胞治……
What is the difference between totipotent, pluripotent and multipotent stem cells?
在学习干细胞时，人们常常会问：全能干细胞（Totipotent）、多能干细胞（Pluripotent）和多潜能干细胞（Multipotent）之间有什么区别？答案其实很简单。 全能、多能和多潜能干细胞有什么区别？ 它们的主要区别在于……
3 Stroke Patients in Their Own Words: Real Changes and Journeys after Stroke with Stem Cell Therapy
在中风治疗领域，干细胞疗法正在从实验室研究逐渐走向临床。相比传统康复训练对运动、语言等功能的有限改善，干细胞通过神经再生、血管修复、免疫调节等机制，为中枢神经功能的恢复提供了新的可能。相比媒体对“干……
Updated review: comparing clinical efficacy of stem cell therapy for neurotrauma and neurodegenerative diseases reported
神经创伤性疾病，例如脊髓损伤、脑损伤，以及神经退行性疾病，例如肌萎缩侧索硬化症，因其复杂性和治疗的细微差别，对康复领域构成了挑战。几十年来，人们一直在探索细胞疗法在神经康复疾病治疗中的应用，以补充目……
Stem cells vs. traditional rehabilitation: which option provides faster recovery in post-stroke treatment?
中风后遗症困扰着约70%的幸存者，偏瘫、失语、认知障碍等问题严重影响生活质量。患者常问：”哪种方法能让我更快恢复？”面对这一问题，传统康复训练与新兴的干细胞疗法成为两大选择。传统方法安全成熟但效果有限，……
Which stroke patients are suitable for stem cell therapy? Experts unveil 5 major evaluation criteria
近几年，干细胞治疗中风在医学界热度不断上升。理论上，这类干细胞疗法可以促进神经再生、改善受损脑组织、调节免疫反应，甚至有望减缓偏瘫、失语等后遗症的进展；但它并非万能钥匙，并非所有中风患者都适合尝试。……
China's first stem cell drug clinical success! First critically ill patient cured and discharged from hospital
9月14日，央视新闻频道报道显示，我国目前唯一获批的干细胞新药——艾米迈托赛注射液，在临床应用中取得重要突破，首位接受该药治疗的患者已成功出院。 该药由本土企业铂生生物自主研发，主要用于治疗14岁以上、以消……